Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Christopher J Bakkenist
Affiliation
UPMC Hillman Cancer Center, University of Pittsburgh
ORCID
Career Start Year
1994
Papers
79
H Index
32
Expertise
CM4AI Collaborator
Trey Ideker (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36810257
The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy.
JCI Insight
2023
37639904
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment.
Gynecol Oncol
2023
37145994
Mitotic CDK1 and 4E-BP1 I: Loss of 4E-BP1 serine 82 phosphorylation promotes proliferative polycystic disease and lymphoma in aged or sublethally irradiated mice.
PLoS One
2023
35066692
Dose-dependent bioavailability and tissue distribution of the ATR inhibitor AZD6738 (ceralasertib) in mice.
Cancer Chemother Pharmacol
2022
35507041
Dose-dependent bioavailability, absorption-rate limited elimination, and tissue distribution of the ATR inhibitor BAY-1895344 (elimusertib) in mice.
Cancer Chemother Pharmacol
2022
36130512
Thymidine rescues ATR kinase inhibitor-induced deoxyuridine contamination in genomic DNA, cell death, and interferon-α/β expression.
Cell Rep
2022
33351788
Syngeneic tobacco carcinogen-induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden.
JCI Insight
2021
33513208
Human FcRn expression and Type I Interferon signaling control Echovirus 11 pathogenesis in mice.
PLoS Pathog
2021
34223192
Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients.
Nat Cancer
2021
34158341
Radiopotentiation Profiling of Multiple Inhibitors of the DNA Damage Response for Early Clinical Development.
Mol Cancer Ther
2021
30808762
The neonatal Fc receptor is a pan-echovirus receptor.
Proc Natl Acad Sci U S A
2019
31665741
The human Shu complex functions with PDS5B and SPIDR to promote homologous recombination.
Nucleic Acids Res
2019
31712441
WEE1 kinase inhibitor AZD1775 induces CDK1 kinase-dependent origin firing in unperturbed G1- and S-phase cells.
Proc Natl Acad Sci U S A
2019
31239318
IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor Cell.
Cancer Immunol Res
2019
31209037
An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication.
Proc Natl Acad Sci U S A
2019
31176958
Quantitative analysis of ATM phosphorylation in lymphocytes.
DNA Repair (Amst)
2019
31345392
ATR inhibition sensitizes HPV<sup>-</sup> and HPV<sup>+</sup> head and neck squamous cell carcinoma to cisplatin.
Oral Oncol
2019
31311769
Dormant origin signaling during unperturbed replication.
DNA Repair (Amst)
2019
29173750
Role of Immunotherapy in Head and Neck Cancer.
Semin Radiat Oncol
2018
29952768
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiation.
J Clin Invest
2018
30266203
Regulation of the initiation of DNA replication in human cells.
DNA Repair (Amst)
2018
30316683
ATM Is Required for the Repair of Oxaliplatin-Induced DNA Damage in Colorectal Cancer.
Clin Colorectal Cancer
2018
30559436
Kinase-dead ATR differs from ATR loss by limiting the dynamic exchange of ATR and RPA.
Nat Commun
2018
29568381
Nuclear myosin/actin-motored contact between homologous chromosomes is initiated by ATM kinase and homology-directed repair proteins at double-strand DNA breaks to suppress chromosome rearrangements.
Oncotarget
2018
28888173
LC-MS/MS assay for the quantitation of the ATR kinase inhibitor VX-970 in human plasma.
J Pharm Biomed Anal
2017
28254357
RAD-ADAPT: Software for modelling clonogenic assay data in radiation biology.
DNA Repair (Amst)
2017
28213176
LC-MS/MS assay for the simultaneous quantitation of the ATM inhibitor AZ31 and the ATR inhibitor AZD6738 in mouse plasma.
J Pharm Biomed Anal
2017
28145510
Pharmacologic ATM but not ATR kinase inhibition abrogates p21-dependent G1 arrest and promotes gastrointestinal syndrome after total body irradiation.
Sci Rep
2017
29123096
ATR kinase inhibition induces unscheduled origin firing through a Cdc7-dependent association between GINS and And-1.
Nat Commun
2017
27259260
ATM protein is deficient in over 40% of lung adenocarcinomas.
Oncotarget
2016
27235625
Human DNA polymerase ε is phosphorylated at serine-1940 after DNA damage and interacts with the iron-sulfur complex chaperones CIAO1 and MMS19.
DNA Repair (Amst)
2016
25560806
Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.
Gynecol Oncol
2015
26517239
The orally active and bioavailable ATR kinase inhibitor AZD6738 potentiates the anti-tumor effects of cisplatin to resolve ATM-deficient non-small cell lung cancer in vivo.
Oncotarget
2015
26517194
ATM serine-1981 phosphorylation is a plausible biomarker.
Cell Cycle
2015
26438152
Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma : ATM, ATR and FA in lung carcinoma.
BMC Cancer
2015
26391293
Chromatin perturbations during the DNA damage response in higher eukaryotes.
DNA Repair (Amst)
2015
26097887
A quasi-quantitative dual multiplexed immunoblot method to simultaneously analyze ATM and H2AX Phosphorylation in human peripheral blood mononuclear cells.
Oncoscience
2015
24799566
Simian virus 40 large T antigen induces IFN-stimulated genes through ATR kinase.
J Immunol
2014
23370393
Homologous chromosomes move and rapidly initiate contact at the sites of double-strand breaks in genes in Gâ¿¿-phase human cells.
Cell Cycle
2013
24312743
Erratum: Investigation of depth-resolved nanoscale structural changes in regulated cell proliferation and chromatin decondensation: erratum.
Biomed Opt Express
2013
24045152
Brd4 shields chromatin from ATM kinase signaling storms.
Sci Signal
2013
24038466
ATR kinase activation in G1 phase facilitates the repair of ionizing radiation-induced DNA damage.
Nucleic Acids Res
2013
24189535
Stoichiometry of ubiquitin-binding proteins directs DSB repair.
Cell Cycle
2013
23900392
Radiation therapy induces the DNA damage response in peripheral blood.
Oncotarget
2013
23577294
Investigation of depth-resolved nanoscale structural changes in regulated cell proliferation and chromatin decondensation.
Biomed Opt Express
2013
22362778
ATM protein physically and functionally interacts with proliferating cell nuclear antigen to regulate DNA synthesis.
J Biol Chem
2012
23015593
Mitochondrial hyperfusion induced by loss of the fission protein Drp1 causes ATM-dependent G2/M arrest and aneuploidy through DNA replication stress.
J Cell Sci
2012
22909323
Quantitative proteomics reveal ATM kinase-dependent exchange in DNA damage response complexes.
J Proteome Res
2012
22869596
Kinase-dead ATM protein causes genomic instability and early embryonic lethality in mice.
J Cell Biol
2012
22645362
Homologous chromosomes make contact at the sites of double-strand breaks in genes in somatic G0/G1-phase human cells.
Proc Natl Acad Sci U S A
2012
1 - 50 of 79
Column Actions
Search
Recommended Authors
Amrita Sule
Yale University
Career Start Year
2015
Number of shared co-authors
0
Marc Wiedner
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Career Start Year
2013
Number of shared co-authors
1
Jordi Carreras Puigvert
Department of Pharmaceutical Biosciences, Uppsala University
Career Start Year
2009
Number of shared co-authors
0
Srikanth Talluri
VA Boston Healthcare System
Career Start Year
2008
Number of shared co-authors
0
Jianfeng Li
Mitchell Cancer Institute, University of South Alabama
Career Start Year
2008
Number of shared co-authors
6
Georgia Velimezi
University of Patras
Career Start Year
2008
Number of shared co-authors
1
Abdelghani Mazouzi
Netherlands Cancer Institute
Career Start Year
2005
Number of shared co-authors
1
Mateusz Koptyra
Children's Hospital of Philadelphia
Career Start Year
2004
Number of shared co-authors
0
Denise P Mu??oz
Helen Diller Family Comprehensive Cancer Center
Career Start Year
2004
Number of shared co-authors
1
Joanna I Loizou
Center for Cancer Research, Comprehensive Cancer Centre, Medical University of Vienna
Career Start Year
2002
Number of shared co-authors
1
Tarek Abbas
University of Virginia
Career Start Year
2001
Number of shared co-authors
0
Nuala McCabe
Queen's University Belfast
Career Start Year
2001
Number of shared co-authors
0
Junjie Chen
The University of Texas MD Anderson Cancer Center
Career Start Year
2000
Number of shared co-authors
1
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Career Start Year
1999
Number of shared co-authors
2
Claudia Lukas
Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
Career Start Year
1999
Number of shared co-authors
0
Dipanjan Chowdhury
Dana-Farber Cancer Institute
Career Start Year
1999
Number of shared co-authors
0
Thomas Helleday
The University of Sheffield
Career Start Year
1998
Number of shared co-authors
1
Marcus B Smolka
Weill Institute for Cell and Molecular Biology, Cornell University
Career Start Year
1998
Number of shared co-authors
1
Ranjit S Bindra
Yale University School of Medicine
Career Start Year
1997
Number of shared co-authors
0
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Career Start Year
1997
Number of shared co-authors
0
Shiaw-Yih Lin
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
2
Daniel Durocher
The Lunenfeld-Tannenbaum Research Institute, Mount Sinai Hospital
Career Start Year
1995
Number of shared co-authors
0
Peter D Adams
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
1991
Number of shared co-authors
1
Susan P Lees-Miller
University of Calgary, 0 Hospital Drive NW
Career Start Year
1989
Number of shared co-authors
0
Stephen P Jackson
Mission Therapeutics Ltd. Glenn Berge Building
Career Start Year
1987
Number of shared co-authors
3
Robert W Sobol
University of South Alabama
Career Start Year
1987
Number of shared co-authors
7
Feyruz V Rassool
University of Maryland Greenebaum Comprehensive Cancer Center
Career Start Year
1984
Number of shared co-authors
0
Stephen J Elledge
Howard Hughes Medical Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year
1982
Number of shared co-authors
0
Ashok R Venkitaraman
University of Cambridge, Hutchison Research Centre
Career Start Year
1982
Number of shared co-authors
0
Scott H Kaufmann
Mayo Clinic
Career Start Year
1977
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Serah Choi
University Hospitals Cleveland Medical Center and Case Comprehensive Cancer Center
Co-authored papers
14
Thomas P Conrads
Women's Health Integrated Research Center, Inova Health System
Co-authored papers
9
Brian L Hood
The Henry M. Jackson Foundation for the Advancement of Military Medicine
Co-authored papers
4
Simon C Watkins
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Co-authored papers
4
Katherine Y Fu
University of Florida
Co-authored papers
2
George L Maxwell
Women's Health Integrated Research Center, Inova Health System
Co-authored papers
2
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers
2
Gregory A Gibson
University of Pittsburgh
Co-authored papers
2
Bennett Van Houten
UPMC-Hillman Cancer Center, University of Pittsburgh
Co-authored papers
2
Kathleen M Darcy
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Co-authored papers
2
Nathan A Yates
University of Pittsburgh School of Medicine
Co-authored papers
1
Rohith Srivas
Amgen Inc.
Co-authored papers
1
Jennifer R Grandis
University of California san francisco
Co-authored papers
1
Nuno Bandeira
University of California
Co-authored papers
1
Uma R Chandran
Co-authored papers
1
John Paul Shen
The University of Texas MD Anderson Cancer Center
Co-authored papers
1
Jian Peng
University of Illinois
Co-authored papers
1
Daniel E Johnson
University of California San Francisco
Co-authored papers
1
Marc Hafner
Harvard Medical School
Co-authored papers
1
Riyue Bao
UPMC Hillman Cancer Center
Co-authored papers
1
Yunan Luo
Georgia Institute of Technology
Co-authored papers
1
Marjorie Romkes
Co-authored papers
1
Anish Bhaswanth Chakka
Co-authored papers
1
Xandra O Breakefield
Massachusetts General Hospital
Co-authored papers
1
Jianzhu Ma
Purdue University
Co-authored papers
1
Hua Li
University of California san francisco
Co-authored papers
1
Hussein A Tawbi
MD Anderson Cancer Center
Co-authored papers
1
Joshua Armenia
Oncology R&D
Co-authored papers
1
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Co-authored papers
1
Maria L Cortés
Co-authored papers
1
1 - 30